Research Progress of the Liver–Brain Cotreatment of Depression with Supplemented Danzhi Xiaoyao Powder

Abstract

Traditional Chinese medicine (TCM) has unique advantages in preventing and treating depression based on holistic concepts and syndrome differentiation and treatment. Liver depression and spleen deficiency are the main syndrome of depression. Danzhi Xiaoyao powder has the efficacy of soothing the liver and relieving depression, nourishing blood, and strengthening spleen. Present studies have proven that it has antidepressant efficacy for the syndrome of liver depression and spleen deficiency. The basic research on pharmacodynamic substances has found that the main active ingredients of Danzhi Xiaoyao powder in the treatment of depression include bupleurum saponin, paeonol, gardenoside, angelica polysaccharide, sulfate polysaccharide, paeoniflorin, albiflorin, atractylone, etc. In clinical practice, Danzhi Xiaoyao powder is often modified to make it more suitable according to the characteristics of pathogenesis and changes in the disease condition. Our research group has found that “brain and spirit failure and liver failing to disperse” are the main pathogenesis of depression. Based on the theory of “liver–brain cotreatment,” the treatment principle of “dispersing the liver and relieving depression, strengthening brain and benefiting intelligence” was put forward. On the basis of Danzhi Xiaoyao powder, Shichangpu (Acori Tatarinowii Rhizoma) was added to enlighten the mind and Yuanzhi (Polygalae Radix) to calm the mind and benefit intelligence. The modified Danzhi Xiaoyao powder was formulated, and its clinical effects on depression were remarkable. Animal experiments also confirmed that modified Danzhi Xiaoyao powder can significantly improve the depression-like behavior of depression model rats and the mechanism may be related to the regulation of the hypothalamic–pituitary–adrenal axis, the increase of the content of 5-hydroxytryptamine, and norepinephrine, which provides a reference for the further promotion of the clinical application of modified Danzhi Xiaoyao powder in the treatment of depression.

Keywords

depression - Supplemented Danzhi Xiaoyao powder - liver–brain cotreatment - Shichangpu (Acori Tatarinowii Rhizoma) - Yuanzhi (Polygalae Radix)

Depression is a mental disorder characterized by persistent depression, which may be accompanied by symptoms such as thinking disorders, volitional activity, and cognitive impairment.[1] It has high prevalence rate, high disability rate, high suicide rate, and high recurrence rate.[2] Comorbidities with other diseases gets easily formed.[3] At present, the prevalence rate of depression in China is 6.8%,[4] an increase by 30.99% compared with 10 years ago,[5] and the overall prevention and treatment situation are very severe. Nowadays, the commonly used antidepressant chemicals, such as tricyclic antidepressants and selective serotonin reuptake inhibitors, have disadvantages of slow effect, easy recurrence, many adverse reactions, and narrow antidepressant spectrum. The etiology of depression is complex, and its pathogenesis is not clear yet. The above antidepressant chemicals are ineffective in at least 1/3 of patients with severe depression.[6] [7] [8] Chinese herbs, based on the holistic concept and syndrome differentiation and treatment, can effectively improve the clinical symptoms and quality of life of patients with depression. It has unique advantages in the prevention and treatment of depression, such as stable curative effect, low recurrence rate, few side effects, and good patient compliance.

Liver Depression and Spleen Deficiency is the Main Pathogenesis of Depression

The records of depression in traditional Chinese medicine (TCM) are seen in depression syndrome, lily disease, globus hysteriocus, hysteria (Zangzao), etc., and most of the disease locations are believed to be in the liver.[9] According to Danger Zone of Medicine (Yi Bian), depression is often associated with dysfunction of the liver. The liver is rigid and has a strong nature. The liver qi has the properties of stretching of wood, and it ascends actively.[10] In nature, the growth trend of all trees is to stretch their branches smoothly and extend their nature without suppression. Liver governs dispersing, and all kinds of depression can inhibit liver qi and make it fail to disperse.[11] In the Basic State of Spirit of the Spiritual Pivot (Benshen of Ling Shu), it recorded that “Excessive sorrow and grief in the liver will harm the internal organs and damage the ethereal soul. Damage of the ethereal soul will cause mania, amnesia, unintelligent actions,” and “deficiency of liver qi causes fear while excess of liver qi causes anger.” If the seven emotions of the human body are depressed, the liver fails to act freely and is malnourished, which can further make the liver qi depressed and sick. In clinical treatment, the concept of “depressed liver should be dispersed” is also widely accepted, and the representative prescriptions of soothing the liver and relieving depression include Chaihu Shugan powder and Xiaoyao powder which have been widely used in clinical practice.

At the same time, due to the learning and memory disorders in depression,[12] [13] it is closely related to the qi and blood nutrition around the human body.[14] In the Medical Rules and Regulations(Yi Lin Sheng Mo), it recorded that “the spirit depends on blood and qi of the body. Qi and blood flow in a parallel way and circulate endlessly to generate energy and vitality of life … so the disorder of blood will lead to spirit disorder.” Blood is an important material basis for mental activity and an important carrier for cognition, learning, and memory.[15] Sufficient blood in blood vessels and proper blood circulation are the material basis of intelligent memory. Depressed mood caused by qi stagnation is another important pathogenesis of depression.[16] The spleen is located in the middle energizer of the body, which is the pivot of ascending and descending qi movement of the whole body. The spleen governs thinking, and overthinking leads to qi stagnation. In addition, the spleen and stomach are the acquired foundation, the source of qi and blood, and the material basis of all human activities. Therefore, it is said that “all diseases arise from the failure of the spleen and stomach.” Moreover, most patients with depression may have symptoms of spleen dysfunction such as loss of appetite, emaciation, and fatigue. Therefore, the treatment of depression is often based on the spleen. The syndrome patterns of first-episode depression in the International Chinese Medicine Guidelines for Clinical Practice -First-episode Depression include liver depression and qi stagnation syndrome, liver depression and spleen deficiency syndrome, heart and spleen deficiency syndrome, kidney deficiency and liver depression syndrome, and liver and gallbladder damp-heat syndrome.[17] Literature studies show that liver depression and spleen deficiency are the main syndrome of depression, accounting for 34.19% of all depression syndromes.[18]

Correlated Studies of Danzhi Xiaoyao Powder in the Treatment of Depression

Danzhi Xiaoyao powder is derived from Xue Ji's Summary of Internal Medicine (Nei Ke Zhai Yao) in the Ming Dynasty. It is composed of Danpi (Moutan Cortex) and Zhizi (Gardeniae Fructus) on the basis of Xiaoyao powder with the effects of soothing the liver and clearing heat, relieving depression, strengthening the spleen, and nourishing blood.[19] The whole prescription is composed of Chaihu (Bupleuri Radix), Danpi (Moutan Cortex), Zhizi (Gardeniae Fructus), Danggui (Angelicae Sinensis Radix), Baishao (Paeoniae Radix Alba), Baizhu (Atractylodis Macrocephalae Rhizoma), Fuling (Poria), Shengjiang (Zingiberis Rhizoma Recens), Bohe (Menthae Herba), and processed Gancao (Glycyrrhizae Radix et Rhizoma Praeparata cum Melle), which is a classic prescription for regulating abnormal emotions in TCM. The monarch herb Chaihu (Bupleuri Radix) has the effects of soothing the liver and relieving depression; the minister herb Danggui (Angelicae Sinensis Radix) is for nourishing blood and promoting blood circulation, nourishing yin and moistening dryness, and Baishao (Paeoniae Radix Alba) for softening the liver; the assistant herb Baizhu (Atractylodis Macrocephalae Rhizoma), processed Gancao (Radix et Rhizoma Glycyrrhizae Praeparata cum Melle), and Fuling (Poria) are used to strengthen the spleen to prevent liver depression, subjugating the spleen. When the disease caused by liver disfunction appears, the disease caused by spleen disfunction may be soon involved, so it is necessary to strengthen the spleen first; Bohe (Menthae Herba), as a clear and light herb in nature, can disperse depression and assist Chaihu (Bupleuri Radix) to disperse liver depression. Simmered Shengjiang (Zingiberis Rhizoma Recens) is used to warm the stomach and neutralize; all herbs together have the efficacy of soothing the liver, relieving depression, nourishing blood, and strengthening the spleen.

In clinical practice, some scholars treated poststroke depression with Danzhi Xiaoyao powder combined with acupuncture. It was found that the degree of depression was significantly reduced after treatment, and the contents of serum brain-derived neurotrophic factor (BDNF) and 5-Hydroxytryptamine (5-HT) were significantly increased.[20] [21] Ma[22] found that the total effective rate of Danzhi Xiaoyao powder was up to 92.5% in patients with depression and insomnia after 4 weeks of administration, and there was no recurrence of symptoms after drug discontinuance. Luo et al[23] used Danzhi Xiaoyao powder to treat patients with depression. They found that the depression and anxiety scores of patients were significantly reduced after treatment, and their antidepressant efficacy was comparable to that of Maiprotiline, but the adverse reactions were significantly less than that of Maiprotiline.

In animal experiments, Liu et al[24] found that Danzhi Xiaoyao powder could significantly relieve the depressive behavior of mice with chronic psychological stress. Wang et al[25] found that Danzhi Xiaoyao powder could improve the symptoms of diabetic depression rats by regulating the hypothalamic–pituitary–adrenal axis (HPA). Li et al[26] found that Danzhi Xiaoyao powder could achieve antidepressant effect by regulating the content of hypothalamic monoamine neurotransmitters in chronic stress-depression rats.

Pharmacodynamic Material Basis of Danzhi Xiaoyao powder in the Treatment of Depression

In the Danzhi Xiaoyao powder, Chaihu (Bupleuri Radix), Danpi (Moutan Cortex), Zhizi (Gardeniae Fructus), Danggui (Angelicae Sinensis Radix), Baishao (Paeoniae Radix Alba), Baizhu (Atractylodis Macrocephalae Rhizoma), Fuling (Poria), Gancao (Radix et Rhizoma Glycyrrhizae), and Bohe (Menthae Herba) all have been reported on antidepressant efficacy, which is summarized as follows.

Chaihu (Bupleuri Radix): It is the monarch medicine in Danzhi Xiaoyao powder for soothing the liver and relieving depression. Saponins compounds are the most important active ingredients of Chaihu (Bupleuri Radix), mainly including saponins a, saponins b, saponins c, and saponins d. Among them, saponins a has a higher content, and saponins d has the highest biological activity.[27] It was found that Bupleurum saponins can effectively improve the behavioral performance indicators of rats with chronic stress combined with orphan depression.[28] Bupleurum saponin a can reduce the degree of depression in rats by regulating the imbalance of TH17/Treg cells and the secretion of inflammatory cytokines in depressed rats.[29]

Danpi (Moutan Cortex): Paeonol is the main active ingredient in Danpi (Moutan Cortex). It has been found that Paeonol can reduce the loss of synapses and dendrites in different brain regions induced by chronic unpredictable mild stress (CUMS) through multiple signaling pathways such as GTPase-cofilin1 and GSK3β/calcinerin and improve depressive behavior.[30] Another study showed that paeonol reduces the expression of p65, inhibitor of nuclear factor-κB-α (IκBα), IκB kinase (IKKβ), NOD-like receptor protein 3 (NLRP3) by inhibiting the activation of toll like receptor 4 (TLR4) and nuclear factor-κB (NF-κB) signaling pathways, thereby inhibiting the expression of pro-inflammatory factor tumor necrosis factor-α (TN-αF), interleukin-1β (IL-1β), and interleukin-6 (IL-6), so as to promote the production of anti-inflammatory factor IL-10 and improves depression-like symptoms.[31]

Zhizi (Gardeniae Fructus): Gardenoside can relieve depression-like behavior in chronic mild stress (CMS) rats and reverse the low expression of prefrontal mammalian rapamycin target protein (mTOR), S6K, and brain failure response regulator protein 2 (CRMP2) caused by CMS.[32] The iridoid components in the extracts of Zhizi (Gardeniae Fructus) can significantly improve depression-like symptoms in mice, significantly increase the activity of Akt and mTOR, increase the levels of NR1 and GluRl in the hippocampus, normalize the proportion of AMP-dependent protein kinase receptors and N-methyl-D-aspartic acid receptor (NMDA) receptors, and improve synaptic plasticity.[33] Gardenia total iridoid can relieve depression-like behavior in LPS depression model mice, and its mechanism may be related to the regulation of γ-aminobutyric acid (GABA), glutamic acid (Glu), acetylcholine, 5-HT, and dopamine (DA) levels.[34]

Danggui (Angelicae Sinensis Radix): Angelica polysaccharide can upregulate the mRNA expression of tryptophan hydroxylase 1 (TPH1), increase 5-HT synthesis, increase DA content, increase GABA/GLU ratio, and regulate neurotransmitters to correct the excitatory and inhibitory dysfunction of mice, and improve the depressive behavior of mice in the chronic stress model.[35] Ferulic acid and turpentine ferulate are organic acids and also one of the main effective components in Danggui (Angelicae Sinensis Radix). Their amounts in Danggui (Angelicae Sinensis Radix) are 0.06 and 1.2%, respectively.[36] [37] It has been found that ferulic acid can significantly shorten the immobility time of forced swimming test and tail suspension test in CUMS model mice, and the mechanism may be related to the influence of 5-HT energy nervous system and the regulation of the antioxidant system.[38] [39] Zhang et al[40] found that ferulic acid could improve the pain and depression induced by reserpine and also reverse the changes of SOD, NO, and monoamine transmitters in the hippocampus and frontal cortex of mice induced by reserpine. Liao et al[41] found that the cell-free filtrate of sodium ferulate-induced PC12 cell lysate had an obvious antidepressant effect, and its antidepressant effect was related to the upregulation of nerve growth factor and BDNF and the enhancement of neurogenesis.

Fuling (Poria): Poria cocos polysaccharide sulfate has an antidepressant effect, and its mechanism may be related to the upregulation of hippocampal phosphorylation cAMP response element binding protein (p-CREB) and BDNF protein expression by enhancing the function of hippocampal GluR1 receptor.[42]

Baishao (Paeoniae Radix Alba): Paeoniflorin and albiflorin have obvious antidepressant effects,[43] and the mechanism may be related to the down-regulation of NO/cyclic guanosine monophosphate (cGMP) pathway in the cerebral cortex and hippocampus and the regulation of glutamate and its receptor expression in hippocampus.[44] [45] Paeoniflorin can promote the recovery of neurological function and improve the depressive state in rats with poststroke depression, and the mechanism may be related to the increase of BDNF and pCREB protein expression in hippocampal neurons.[46]

Baizhu (Atractylodis Macrocephalae Rhizoma): Atractylenolide III has significant antidepressant effects on rat lipopolysaccharide (LPS) depression model and CUMS depression model, and its mechanism may be related to its inhibition of the expression of inflammatory factors TNF-α, IL-6, and IL-1β in the hippocampus.[47] Li[48] found that atractylone, atractylenolide I, and atractylenolide II were chemical components which were closely related to the antidepressant activity of Xiaoyao powder in the despair model of mice and rats CUMS model. Gong et al[49] found that atractylenolide I and atractylenolide III could significantly shorten the immobility time of forced swimming and tail suspension experiments in mice and had significant antidepressant effects.

Gancao (Glycyrrhizae Radix et Rhizoma): Liquiritin and its drug-containing serum have protective effects on microglia BVZ glutamate damage. Animal experiments showed that liquiritin could significantly increase the sugar preference rate of CMS model rats and relieve the central symptoms of depression.[50] [51] The possible mechanism of depression may be related to the inhibition of 5-HT and norepinephrine (NE) reuptake by neurons in the synaptic space.[52] In addition, liquiritin can inhibit the expression of apoptosis-promoting factor Bax in the prefrontal cortex of rats with poststroke depression and promote the expression of antiapoptotic factors B cl-2 and BDNF.[53] Studies showed that the glycyrrhiza flavonoids could significantly improve the stress-depression behavior of CUS rats,[54] increase the expression of Bcl-xl protein in the hippocampus and reduce the expression of caspase-3 protein,[55] significantly increase the expression of synaptophysin (SYP) mRNA and protein in the hippocampus, reduce the expression of post-synaptic density-95 (PSD-95) mRNA and protein, and improve synaptic plasticity.[56] In addition, studies have shown that the extraction areas of glycyrrhiza flavonoids have obvious antidepressant activity in mice, and its mechanism may be related to the enhancement of central 5-HT functional and neurological functions.[57]

Bohe (Menthae Herba): L-menthone has antidepressant effects, and its antidepressant mechanism may be related to the inhibition of the overactivation of HPA axis and the promotion of BDNF expression in the cerebral cortex.[58]

Research Status of Danzhi Xiaoyao Powder

TCM therapies are characterized by embodying the concept of holism and syndrome differentiation and treatment through the combination or compatibility of prescriptions. In clinical practice, Danzhi Xiaoyao powder is often modified to be more suitable for the pathogenesis and changes of the disease condition. Tian and Li[59] added seven kinds of herbs on the basis of Danzhi Xiaoyao Powder, namely, Yujin (Curcumae Radix), fried Suanzaoren (Ziziphi Spinosae Semen), Baiziren (Platycladi Semen), Yejiaoteng (Caulis Polygoni Multiflori), Hehuanpi (Albiziae Cortex), raw Longgu (Os Draconis) and Muli (Ostreae Concha), and Lianzixin (Nelumbinis Plumula). The formula was based on Danzhi Xiaoyao decoction to disperse the liver and strengthen the spleen. Fried Suanzaoren (Ziziphi Spinosae Semen), Baiziren (Platycladi Semen), Yejiaoteng (Caulis Polygoni Multiflori), Yuanzhi (Polygalae Radix), and Shichangpu (Acori Tatarinowii Rhizoma) can nourish the heart and calm the mind, and Longgu (Draconis Os) and Muli (Ostreae Concha) can suppress yang and calm the heart and mind. The whole prescription was used to relieve liver qi stagnation, nourish the heart, and calm the mind. Chen[60] added Shichangpu (Acori Tatarinowii Rhizoma), Yujin (Curcumae Radix), and Yuanzhi (Polygalae Radix) on the basis of Danzhi Xiaoyao powder. He believed that Shichangpu (Acori Tatarinowii Rhizoma) and Yujin (Curcumae Radix) could relieve depression and regulate the mind, Yuanzhi (Polygalae Radix) could calm the heart and mind and open the orifices, and the whole prescription could relieve the liver depression and induce resuscitation. Deng, on the basis of Danzhi Xiaoyao Powder, added Hehuanpi (Albiziae Cortex) and Yejiaoteng (Caulis Polygoni Multiflori) to nourish blood and calm the mind, aiming at harmonizing the viscera, regulating qi, and promoting blood circulation so as to calm the mind.[61] Clinical application also showed that the antidepression effect of supplemented Danzhi Xiaoyao powder was significantly better than that of Deanxit group. Zhang[62] added Yujin (Curcumae Radix) and Xiangfu (Cyperi Rhizoma) on the basis of Danzhi Xiaoyao powder to enhance its function of promoting qi flow and relieving depression, and the clinical application of 30 patients with depression confirmed that it had a significant antidepressant effect. Song et al[63] added Dannanxing (Arisaema cum Bile), Shichangpu (Acori Tatarinowii Rhizoma), and Chuanxiong (Chuanxiong Rhizoma) to Danzhi Xiaoyao powder. He believed that Dannanxing (Arisaema cum Bile) and Shichangpu (Acori Tatarinowii Rhizoma) could resolve phlegm and induce resuscitation, Chuanxiong (Chuanxiong Rhizoma) could activate blood and qi flow. The prescription can simultaneously regulate qi, resolve phlegm, and disperse liver depression, which effectively aims at the poststroke pathogenesis of qi stagnation and phlegm accumulation confusing the mind and shows a remarkable antidepressant effect in clinical application.

Exploring the Efficacy and Mechanism of Supplemented Danzhi Xiaoyao Powder in the Treatment of Depression Based on the Theory of “Liver–Brain Cotreatment”

We believe that depression, as an emotional disease, affects the liver, hampering the function of conveyance and dispersion as the basic pathogenesis. As the residence of the primordial spirit, the brain also plays a key role in regulating human's spirit and thinking. It can be seen that depression is most related to liver and brain. The brain is the pivotal part of life, which dominates the life activities of the human body. As it is said in the Cun Shou Jiu Gong Tai Yi Zi Fang Jue, “the brain is the spiritual clan of the whole body, the life of all spirit.” The brain is in charge of the mental activities of the human body, including thinking, consciousness, and emotional activities. These are the results of objective things reflected in the material-based brain. According to Categorized Patterns with Clear-Cut Treatments (Lei Zheng Zhi Cai), it says: “The brain is the residence of the primordial spirit, the sea of essence, and the basis of memory.” In Corrections of Errors of Medical Works (Yi Lin Gai Cuo), it also recognizes that “spiritual memory is not in the heart but in the brain.” Liver governs dredging, regulates qi movement, and stores blood. Harmonious qi and blood promote clear mind and spirit; abnormal dispersion, liver-qi depression, or hyperactivity will lead to mental or emotional disorder. In the long-term clinical practice, our research group put forward the theory of “liver–brain cotreatment” for depression. It is believed that the disease location of depression is in the liver and brain, and the main pathogenesis is “brain and spirit failure and liver failing to disperse” ; it emphasizes that the liver is the source of the disease, and the brain is the transmission place of the disease. The primordial spirit disorder aggravates the failed dispersion of the liver, which are evil to each other and lead to the onset of emotional disorders. And thus “clearing the liver and relieving depression, strengthening the brain and benefiting intelligence” is its important therapeutic principle.[64] [65]

Under the guidance of the theory of “liver-brain co-treatment,” the research group added Shichangpu (Acori Tatarinowii Rhizoma) on the basis of Danzhi Xiaoyao powder to open the orifices and Yuanzhi (Polygalae Radix) to tranquilize the mind and benefit intelligence. The combined prescription of supplemented Danzhi Xiaoyao powder has been prepared as an in-hospital preparation of the First Affiliated Hospital of Henan University of Chinese Medicine. In the long-term clinical application, 60 patients with depression were treated with supplemented Danzhi Xiaoyao powder and Fluoxetine. The efficacy showed that the total effective rate of supplemented Danzhi Xiaoyao powder was 90%, while the effective rate of Fluoxetine was 76.67%, with a statistical difference.[66] After 8 weeks of administration, the total effective rate of supplemented Danzhi Xiaoyao powder combined with umbilical cord mesenchymal stem cells in the treatment of poststroke depression was significantly higher in the supplemented Danzhi Xiaoyao powder group than that in the control group.[67] Besides, the previous animal experiments of this research group found that supplemented Danzhi Xiaoyao powder could increase the content of 5-HT and NE in the hypothalamus of depression rats, reduce the level of CORT and ACTH in plasma, and regulate the protein expression of glucocorticoid receptors and mineralocorticoid receptors in the hippocampus. Ultrastructural results showed that chronic stress could cause mitochondrial swelling and vacuolar degeneration to hippocampal cells, while supplemented Danzhi Xiaoyao powder could reduce hippocampal neuronal damage caused by stress.[68] [69] [70] [71]

Conclusion

Depression, as a seriously harmful mental disease, has become a global public health problem. Antidepressants commonly used in clinical practice are ineffective in more than 1/3 of patients with severe depression, and they often have many side effects. Chinese herbs have unique advantages in the prevention and treatment of depression based on the characteristics of holistic concept and syndrome differentiation and treatment. Liver depression and spleen deficiency syndrome is the main syndrome pattern of depression. Danzhi Xiaoyao powder has the efficacy of soothing the liver and relieving depression, nourishing blood, and strengthening the spleen, which is exactly suitable for the syndrome of liver depression and spleen deficiency. Previous basic and clinical studies have confirmed the antidepressant effect of Danzhi Xiaoyao powder. The research studies on the pharmacodynamic material basis found that the main active ingredients of Danzhi Xiaoyao powder in the treatment of depression include bupleurum saponin, paeonol, gardenoside, gardenia total iridoid, angelica polysaccharide, ferulic acid, turpentine ferulate, tuckahoe sulfate polysaccharide, paeoniflorin, albiflorin, atractylenolide (I, II, III), liquiritin, glycyrrhiza flavonoids, L-menthone, etc. In the long-term clinical practice, our research group found that “brain and spirit failure and liver failing to disperse” were the main pathogenesis of depression. We put forward the theory of “liver–brain cotreatment” for depression, emphasizing that the liver was the source of the disease and the brain was the transmission place of the disease. Based on the theory of “liver–brain cotreatment,” the treatment principle of “relieving liver depression, strengthening brain, and benefiting intelligence” was further put forward. On the basis of Danzhi Xiaoyao powder, Shichangpu (Acori Tatarinowii Rhizoma) was added to enlighten the mind and Yuanzhi (Polygalae Radix) to calm the mind and benefit intelligence, and thus this combined prescription was the supplemented Danzhi Xiaoyao Powder. The clinical application of supplemented Danzhi Xiaoyao powder in the treatment of depression has been 16 years, and the clinical effect is significant. Animal experiments also confirmed that supplemented Danzhi Xiaoyao powder can significantly improve the depression-like behavior of depression model rats. It is preliminarily found that its mechanism may be related to the regulation of HPA axis and the increase of 5-HT and NE content. To sum up, the theory and experimental study on the “liver–brain cotreatment” of depression with supplemented Danzhi Xiaoyao powder performed by our research group not only help to innovate and develop the theory of TCM but also broaden the thoughts for the clinical treatment of depression.

Conflict of Interest

The authors declare no conflict of interest. Editor note: EX is Editorial Board members of Chinese Medicine and Natural Products . The article was subject to the journal's standard procedures, with peer review handled independently of these Editorial Board members and their research groups.

CRediT Authorship Contribution Statement

Yajing Li: Writing-original draft, and investigation. Baoying Wang: Data curation, Formal analysis, and investigation. Yucheng Li: Methodology, Supervision, and writing-review & editing. Ming Bai: Project administration, and supervision. Erping Xu: Conceptualization, funding acquisition, and supervision.

• References

• 1 McCarron RM, Shapiro B, Rawles J, Luo J. Depression. Ann Intern Med 2021; 174 (05) ITC65-ITC80
• 2 Ebmeier KP, Donaghey C, Steele JD. Recent developments and current controversies in depression. Lancet 2006; 367 (9505): 153-167
• 3 Roest AM, de Vries YA, Al-Hamzawi A. et al; WHO World Mental Health Survey collaborators. Previous disorders and depression outcomes in individuals with 12-month major depressive disorder in the World Mental Health surveys. Epidemiol Psychiatr Sci 2021; 30: e70
• 4 Huang Y, Wang Y, Wang H. et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry 2019; 6 (03) 211-224
• 5 Guo RQ, Hu Y, Min SH. et al. Analysis of the burden and change trend of depression in Chinese residents from 1990 to 2019. Mod Prev Med 2022; 49 (06) 981-985 , 1031
• 6 Yang XC, Li W, Shao LM. Research progress of novel-mechanism based antidepressants. Zhongguo Yaowu Huaxue Zazhi 2018; 28 (03) 237-244 , 256
• 7 Nemeroff CB. The state of our understanding of the pathophysiology and optimal treatment of depression: glass half full or half empty. Am J Psychiatry 2020; 177 (08) 671-685
• 8 Hieronymus F, Lisinski A, Nilsson S, Eriksson E. Influence of baseline severity on the effects of SSRIs in depression: an item-based, patient-level post-hoc analysis. Lancet Psychiatry 2019; 6 (09) 745-752
• 9 Tang XQ, Lei YL, Han ZC. Mechanism of treating depression from liver. Chin J Integr Med Cardio Cerebrovasc Dis 2020; 18 (12) 2001-2003
• 10 Gu MY, Fan X. A brief talk on relationship between physiological characteristics of liver and awaking-sleeping. J Pract Tradit Chin Intern Med 2020; 34 (06) 74-76
• 11 Huo L, Zhang HR, Zhan XH. et al. Evolution of the connotation of “liver controlling dispersion”. J Basic Clin Med 2021; 27 (10) 1533-1535
• 12 Mendes T, Cardoso S, Guerreiro M. et al. Memory awareness in patients with Major Depressive Disorder. J Psychiatr Res 2021; 137: 411-418
• 13 Tan W, Liu Z, Xi C. et al. Decreased integration of the frontoparietal network during a working memory task in major depressive disorder. Aust N Z J Psychiatry 2021; 55 (06) 577-587
• 14 Dlugaj M, Winkler A, Weimar C. et al; Heinz Nixdorf Recall Study Investigative Group. Anemia and mild cognitive impairment in the German general population. J Alzheimers Dis 2016; 49 (04) 1031-1042
• 15 Wang TT, Lei L, Nie H. Discussion of the treatment of learning and memory impairment from the perspective of blood. Chin J Basic Med Tradit Chin Med 2019; 25 (08) 1043-1044 , 1055
• 16 Ma JX, Zhang D, Zhu FS. Based on spleen governing thought to discuss chronic atrophic gastritis with depression and anxiety. Zhonghua Zhongyiyao Xuekan 2018; 36 (10) 2362-2364
• 17 Zhao YH. International clinical practice guideline of Chinese medicine first-episode depression (2019–10–11). World Chin Med 2020; 15 (20) 3157-3159
• 18 Xu LS, Chen Y, Wang MS. et al. The research on the law of TCM clinical syndrome differentiation of depression. J Hubei Univ Chin Med 2017; 19 (03) 37-40
• 19 Xu EP, Mao MD, Shang LZ. et al. Meta-analysis of Danzhi Xiaoyao powder combined with western medicine in depression treatment. Acta Chin Med 2021; 36 (06) 1315-1321
• 20 Zeng XJ, Zhou JF, Xie GY. et al. Effect of Danzhi Xiaoyao powder combined with acupuncture on the expression of BDNF and 5-HT in patients with post-stroke depression. Zhongguo Laonianxue Zazhi 2019; 39 (07) 1562-1566
• 21 Zhang RL, Liu Y. Clinical effect of Danzhi Xiaoyao powder combined with acupuncture in the treatment of patients with post stroke depression. Clin Res Pract 2018; 3 (31) 138-139
• 22 Ma C. Clinical analysis of Danzhi Xiaoyao powder in the treatment of depression related insomnia. China Med Pharm 2011; 1 (17) 119-124
• 23 Luo HC, Qian RQ, Zhao XY. et al. [Clinical observation on effect of Danzhi Xiaoyao powder in treating depression]. Chung Kuo Chung Hsi I Chieh Ho Tsa Chih 2006; 26 (03) 212-214
• 24 Liu RY, Zou YH, Xu L. et al. Danzhi Xiaoyao Powder reduced the scratching behavior exaggerated by chronic psychological stress in mice. Glob Tradit Chin Med 2021; 14 (06) 1007-1012
• 25 Wang XM, Xie B, Zhou ZY. et al. Effects of Danzhi Xiaoyao decoction on insulin receptors and insulin receptor substrate-1 mRNA expression in diabetes mellitus rat with depression. Zhongguo Laonianxue Zazhi 2011; 31 (07) 1181-1183
• 26 Li HY, Shi YB, Jiang YL. Effect of Danzhi Xiaoyao powder capsule on hypothalamic monoamine neurotransmitters in chronic stress depression model. China Med Her 2007; 4 (30) 61-62
• 27 Lv XH, Sun ZX, Su RQ. et al. Pharmacological research progress of Bupleurum Chinense and its active components. Zhongguo Zhongyiyao Xinxi Zazhi 2012; 19 (12) 105-107
• 28 Ge HY, Chen B, Wan YG. Effect of Poria cocos sulfate polysaccharide on AMPA receptor expression in hippocampus of depression rats. Zhongguo Laonianxue Zazhi 2012; 32 (10) 2098-2100
• 29 Guo XT, An JD, Mei JQ. Effect of saikosaponin A on Treg and Th17 immune balance in depressive rats. Hainan Yixueyuan Xuebao 2020; 26 (22) 1686-1690
• 30 Zhu XL. Study on the Effects of Paeonol on Chronic Stress-Induced Neuronal Injury and its Mechanism. Wuhu: Anhui Normal University; 2018
• 31 Guo KY. Study on Inflammation Mechanism of Disorders Caused by the Liver Failing to Convey and Disperse-Research on Paeonol Treating Depression with Liver-Qi Stagnation Through TLR4-NF-κB Signaling Pathway. Jinan: Shandong University of Traditional Chinese Medicine; 2018
• 32 Chen GH, Chen Q, Zhang LL. et al. Effects of gardeniin on the expression of collapsin response mediator protein 2 and potential molecular mechanism in prefrontal cortex of depression model rats. China Pharm 2021; 24 (10) 1794-1799
• 33 Xu J. Study on the Biological Mechanism of Gardenia's Effective Components in Treating Depression. Nanjing: Nanjing University of Chinese Medicine; 2020
• 34 Qu SY, Heng X, Qi YY. et al. Effect of Gardenia iridoid on neurotransmitters in depression model mice. Zhongchengyao 2021; 43 (04) 1022-1027
• 35 Ding C, Xu Y, Ge YZ. Research on the mechanism and the effects of Angelica polysaccharide on the behavior of chronic stress depression mice. World J Tradit Chin Med 2021; 34 (06) 21-27
• 36 Li Y, Xu LZ, LIN J. et al. Comparison of the contents of ferulic acid in Angelica sinensis Oliv from different regions. Chung Kuo Yao Hsueh Tsa Chih 2003; 38 (11) 838-840
• 37 Yu Y, Zhang QW, Wang YT. et al. A rapid HPLC method for determination of coniferyl ferulate in Angelica sinensis and Ligusticum Chuanxiong. J Chin Pharm Sci 2007; 16 (03) 197-201
• 38 Zeni ALB, Zomkowski ADE, Maraschin M, Rodrigues AL, Tasca CI. Ferulic acid exerts antidepressant-like effect in the tail suspension test in mice: evidence for the involvement of the serotonergic system. Eur J Pharmacol 2012; 679 (1-3): 68-74
• 39 Lenzi J, Rodrigues AF, Rós AdeS. et al. Ferulic acid chronic treatment exerts antidepressant-like effect: role of antioxidant defense system. Metab Brain Dis 2015; 30 (06) 1453-1463
• 40 Zhang L, Wang QD, Shi HM, Pan JC. Influence of ferulic acid on the pain-depression dyad induced by reserpine. Yao Xue Bao 2013; 48 (01) 32-37
• 41 Liao MN, Yu LJ, Zhang YP. et al. Antidepressant-like effect of cell-free filtrate of sodium ferulate-induced and differentioned PC12 cell lysates. Chin J Cell Biol 2011; 33 (06) 608-621
• 42 Tang J, Zhang Q, Ding BP. et al. Effect of Poria cocos sulfate polysaccharide on AMPA receptor expression in hippocampus of depression rats. Zhongguo Yaolixue Yu Dulixue Zazhi 2019; 33 (06) 449
• 43 Zhang JJ, Wang JX, Li W. et al. Study on the antidepressant-like effect of albiflorin. Pharm Clin Chin Mater Med 2011; 2 (06) 35-37
• 44 Wu L, Wang LL, Li W. et al. Correlation study on antidepressant effect of paeoniflorin and albiflorin and NO/cGMP signal transduction pathway. World Chin Med 2018; 13 (07) 1714-1717 , 1722
• 45 Li W, Wang JX, Ge Y. et al. Effects of paeoniflorin on expression of Glu and different glutamate receptors in hippocampus of rats with syndrome of stagnation of liver qi and blood deficiency. Zhonghua Zhongyiyao Zazhi 2016; 31 (04) 1241-1244
• 46 Hu MZ. Effects of Paeoniflorin on PSD Rats and Mentor's Clinical Experiences of PSD. Jinan: Shandong University of Traditional Chinese Medicin; 2018
• 47 Zhou Y. Study on the Antidepressant Effect and Mechanism of Atractylenolide III. Changsha: Hunan Normal University; 2021
• 48 Li JB. Screening the Best Compatibility and Investigation on the Spectrum-Effect Relationships of Active Fractions from Xiaoyaosan. Taiyuan: Shanxi University; 2013
• 49 Gong WX, Zhou YZ, Qin XM. et al. Application of Atractylodes Lactone in the Preparation of Antidepressants: CN105582006B[P]. 2019–02–26
• 50 Xiao Y. Antidepressant Effect of Glycyrrhizin and its Mechanism. Beijing: Beijing University of Chinese Medicine; 2009
• 51 Zhao ZY, Wang WX, Guo HZ. et al. Anti-depressive effect of liquiritin on chronic stress depression in rats. Zhongguo Linchuang Kangfu 2006; 10 (27) 69-72
• 52 Li HF. Study of Liquiritin to Treat Depression on Pharmacodynamics and its Possible Antidepressant Mechanisms. Beijing: Beijing University of Chinese Medicine; 2008
• 53 Wang XY, Li Y, Zhu HX. et al. Effect of liquiritin on expressions of BDNF, Bax and Bcl-2 in prefrontal cortex of poststroke depression rats. Chin J Geriatr Heart Brain Vessel Dis 2021; 23 (06) 647-650
• 54 Guo J, Zhao WH, Fan ZZ. et al. Effects of the flavonoids extracted parts on antidepressant activities from Glycyrrhiza uralensis . Pharmacol Clin Chin Mater Med 2012; 28 (06) 59-62
• 55 Cheng RF, Hua B, Jing J. et al. Modulation of the apoptotic protein expression in hippocampus is associated with the antidepressant effects of licorice flavonoids from Glycyrrhiza uralensis in rats. Pharmacol Clin Chin Mater Med 2014; 30 (02) 69-72
• 56 Hua B, Cheng RF, Jing J. et al. Antidepressant effect of licorice flavonoids from Glycyrrhiza uralensis on stress-induced depression and the key protein SYP/PSD95 associated with synaptic plasticity in rats. Zhongguo Xin Yao Zazhi 2014; 23 (10) 1180-1187
• 57 Cheng RF, Jing J, Hua B. et al. Anti-depression effect of licorice flavonoids from Glycyrrhiza uralensis through promotion of central serotonergic neural function in mice. Zhongguo Yaolixue Yu Dulixue Zazhi 2014; 28 (04) 484-490
• 58 Xue JS, Li HY, Fu Q. et al. Antidepressant-like effects of L-menthone in depressed mice and its possible mechanisms. Pharm Clin Res 2015; 23 (03) 238-241
• 59 Tian Q, Li BH. 48 cases of depression treated with modified Danzhi Xiaoyao Decoction. Mod Tradit Chin Med 2011; 31 (06) 10-11
• 60 Chen GX. 45 cases of post-stroke depression treated with modified Danzhi Xiaoyao Powder. Guangming J Chin Med 2009; 24 (10) 1901-1902
• 61 Deng Y. Clinical observation on the treatment of generalized anxiety disorder with modified Danzhi Xiaoyao Powder. Guangming J Chin Med 2016; 31 (22) 3292-3294
• 62 Zhang HW. Treating 30 cases of depression with Danzhi Xiaoyao San. Clin J Chin Med 2015; 7 (28) 117-118
• 63 Song GM, Yang J. Clinical observation of modified Danzhi Xiaoyao powder in treating post-stroke depression. Tianjin J Tradit Chin Med 2008; 25 (04) 296-298
• 64 Zhang JS. Discussion on the relationship between depression and liver and brain. J New Chin Med 2008; 40 (07) 106
• 65 Zhang LN, Zhang JS, Hui XS. et al. Professor Zhang Jinsheng's experience of applying the theory of “simultaneous management of liver and brain” in treating depression. Clin J Chin Med 2019; 11 (09) 1-2
• 66 Xu EP. Clinical and Experimental Study of Danzhi Xiaoyaosan Jiawei Capsule in Treating Depression. Nanjing: Nanjing University of Chinese Medicine; 2007
• 67 Chen XH, Wang GQ, Shang LZ. et al. Therapeutic effect of Jiawei Danzhi Xiaoyao powder combined with intravenous human umbilical cord mesenchymal stem cells on post-stroke depression. Chin J Pathophysiol 2019; 35 (12) 2274-2279
• 68 Guo XD, Xu EP, Li L. et al. Effect of modified Danzhi Xiaoyao Powder on 5-HT and NE in hypothalamus of depression model in rats. China J Chin Med 2013; 28 (12) 1831-1833
• 69 Xu EP, Guo XD, Li L. et al. Effect of Jiawei Danzhi Xiaoyao powder on the function of HPA in the depression rats. Zhongguo Shiyan Fangjixue Zazhi 2013; 19 (10) 236-238
• 70 Guo XD, Xu EP, Li L. et al. Effect of Jiawei Danzhi Xiaoyao powder on mineralocorticoid receptor and glucocorticoid receptor in Hippocampus of depression rats. Zhongguo Shiyan Fangjixue Zazhi 2014; 20 (11) 119-122
• 71 Gong SL, Fu WJ, Huang BQ. et al. Review on mechanism of hippocampal neural plasticity damage during depression and Danzhi Xiaoyao powder regulation. Liaoning J Tradit Chin Med 2016; 43 (03) 663-666

Publikationsverlauf

Eingereicht: 24. Februar 2022

Angenommen: 14. April 2022

Artikel online veröffentlicht:
27. Oktober 2022